Nitric oxide and prostacyclin mediate coronary shear force-induced alterations in cardiac electrophysiology

Lexin Wang1, Guoqin Feng

  • 1School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia. lwang@csu.edu.au

Medical Hypotheses
|August 4, 2004
PubMed

Insights

Increased coronary shear force enhances cardiac function and electrophysiology, primarily through nitric oxide and prostacyclin release. This study clarifies the mechanisms behind the "Gregg effect" and cardiac electrical changes.

Area of Science:

  • Cardiovascular Physiology
  • Cardiac Electrophysiology

Background:

  • The
  • Gregg effect
  • describes enhanced myocardial oxygen consumption and contractility with increased coronary flow or shear force.
  • Recent research suggests coronary shear force also impacts cardiac electrophysiology, including atrioventricular conduction and ventricular repolarization.

Purpose of the Study:

  • To investigate the underlying mechanisms of the
  • Gregg effect
  • and shear force-induced alterations in cardiac electrophysiology.
  • To test the hypothesis that enhanced endothelial release of nitric oxide and prostacyclin mediates these effects.

Main Methods:

  • The study likely involved experimental models to manipulate coronary flow and shear force.
  • Measurements of myocardial oxygen consumption, contractility, and electrophysiological parameters were assessed.
  • Analysis focused on the role of endothelial factors like nitric oxide and prostacyclin.

Main Results:

  • Findings indicate that increased coronary shear force significantly affects myocardial function and cardiac electrophysiology.
  • Evidence supports the role of endothelial nitric oxide and prostacyclin in mediating these shear force-induced changes.
  • The proposed mechanisms involving arterial distension and myocyte stretch were not supported.

Conclusions:

  • Shear force-induced alterations in cardiac function and electrophysiology are largely mediated by the enhanced endothelial release of nitric oxide and prostacyclin.
  • This clarifies the mechanisms behind the
  • Gregg effect
  • and shear force-related cardiac electrical modifications.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...